GOS (Galactooligosaccharides).

GOS mimics the galactose-linked structures of human milk oligosaccharides that B. infantis is specialised to import and cleave. It is the closest commercial substrate match for that organism.

B. longum carries beta-galactosidases that liberate galactose from GOS chains for the bifid shunt. Co-dosing supplies the delivered strain with a substrate few competitors can use.

B. lactis ferments galactooligosaccharides to acetate and lactate, acidifying its immediate environment. The fibre is the carbon source that keeps the co-dosed culture active.

Lactobacilli use beta-galactosidase to break GOS down and ferment it to lactic acid. The resulting pH drop favours the delivered strain over acid-sensitive organisms.

GOS needs galactosidases while FOS needs fructofuranosidases, so the two recruit partly different bacterial populations. The 9:1 GOS to FOS blend is long-standing formulation practice for that reason.

GOS ferments early in the proximal colon while long-chain inulin carries into the distal colon. Pairing them extends the reach of fermentation instead of concentrating it in one segment.

Short-chain fatty acids from GOS fermentation lower colonic pH, holding calcium in the soluble ionised form available for uptake in the large bowel. This is the settled mechanism behind prebiotic and calcium pairings.

The same acidification from GOS fermentation keeps magnesium in solution at distal absorptive sites. The effect is smaller than for calcium but runs through the identical route.

Bifidobacteria fermenting GOS release acetate and lactate that butyrate-forming species convert onward. The fibre raises butyrate made in the colon while a direct dose covers the upper segment.

XOS carries a xylose backbone requiring xylanase-type enzymes rather than the galactosidases GOS needs. Blending widens which resident populations can respond to the dose.

Unabsorbed magnesium citrate draws water into the lumen while GOS fermentation adds gas and osmotically active acids. Stacked at full doses the two add up to bloating and urgency.

GOS is manufactured by running beta-galactosidase, the same enzyme sold as lactase, on concentrated lactose so that it transfers galactose onto other sugars instead of onto water. Supplemental lactase in the gut can hydrolyse the shorter GOS chains back toward galactose and glucose, which removes the substrate the colonic bacteria were meant to ferment. Anyone taking both should expect the prebiotic fraction to be partly digested rather than reaching the colon intact.

Lactoferrin is an iron-binding milk glycoprotein with documented selective effects on gut bacterial growth, and it is a conventional partner for GOS in milk-based formulas. The two act by different means: one binds iron and interacts with bacterial surfaces, the other supplies a fermentable substrate. Their pairing is well established in formulation even where combination data in adults is thin.

Resistant starch escapes small-intestinal amylase and is fermented mainly in the distal colon, where it favours butyrate production. GOS ferments faster and more proximally. Combining a fast and a slow substrate spreads fermentation along the colon rather than concentrating gas production in one segment.

Pectin is a fermentable soluble fibre that yields largely acetate and propionate and also forms a gel that slows transit. GOS is a short, rapidly fermented oligosaccharide. The two produce different short-chain fatty acid profiles from the same meal.

Partial hydrolysis lowers guar gum's viscosity while keeping it fermentable, which is why it is tolerated at doses whole guar gum is not. Paired with GOS it adds a slower-fermenting substrate to a fast one. Both feed the same saccharolytic bacteria at different rates.

Unhydrolysed guar gum forms a highly viscous gel that slows gastric emptying and glucose absorption, and it is also fermented in the colon. Stacking it with GOS raises the total fermentable load in one dose, which is the usual cause of bloating and flatulence. Building the dose up gradually is the practical answer.

Oat beta-glucan is a viscous soluble fibre that is fermented in the colon and is separately recognised for its effect on blood cholesterol handling through bile acid binding. GOS contributes no viscosity at all. In one formula they cover the viscous and non-viscous sides of soluble fibre.

Psyllium is only partly fermented and works largely by holding water in a gel, which affects stool form and transit. GOS is fully fermented and produces gas doing it. Pairing a mostly non-fermented bulking fibre with a rapidly fermented oligosaccharide is a common way to get bulk without adding to gas load.

Saccharomyces boulardii is a yeast, not a bacterium, and it does not ferment GOS the way bifidobacteria do. It transits rather than colonising and acts through its own surface and secreted activity. Combining the two is not a feeding relationship, which is worth saying plainly rather than assuming any prebiotic feeds any probiotic.

Many Lactobacillus plantarum strains carry beta-galactosidase and can use galactooligosaccharides as a carbon source, though the ability is strain-specific rather than species-wide. Where the strain has that capability, GOS provides a substrate for it. Where it does not, the pairing is simply two ingredients in one capsule.

Fermentation of GOS produces short-chain fatty acids that lower colonic pH, and calcium salts are more soluble at lower pH, which supports absorption in the large bowel in addition to the active vitamin D-dependent route in the small intestine. Calcium carbonate is the least soluble common calcium salt and depends most on an acid environment. The mechanism is established; the size of the contribution varies with dose and diet.

A 2025 study paired dietary prebiotics with iron supplementation and measured the effect on how much dietary cadmium was taken up, reporting that the two-pronged approach reduced bioavailability of the metal. The work was not done in humans, so it grounds a mechanism rather than a human effect. Unabsorbed iron reaching the colon also alters which bacteria are favoured there, which is a second reason the pairing is worth flagging.

Chicory inulin is a fructan with a longer average chain length than GOS, so it ferments more slowly and further along the colon. Blending the two gives a broader window of substrate availability. It also stacks total fermentable load, which is the dose-limiting factor for gas and bloating.

Broad digestive enzyme blends often contain carbohydrases, including lactase and sometimes alpha-galactosidase, whose whole purpose is to break down oligosaccharides before they reach the colon. That works directly against a prebiotic dose intended to arrive intact. Where a blend is being taken to reduce fermentation gas, it will reduce the prebiotic effect along with it.

Enteric-coated peppermint oil relaxes intestinal smooth muscle through calcium channel effects and is used for gastrointestinal comfort. GOS commonly causes transient gas and bloating as the dose is built up. The pairing is a practical formulation response to that, not a documented interaction.